These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26708211)

  • 1. Sublingual administration of atropine eyedrops in children with excessive drooling - a pilot study.
    Norderyd J; Graf J; Marcusson A; Nilsson K; Sjöstrand E; Steinwall G; Ärleskog E; Bågesund M
    Int J Paediatr Dent; 2017 Jan; 27(1):22-29. PubMed ID: 26708211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy.
    Dias BLS; Fernandes AR; Maia HS
    Arq Neuropsiquiatr; 2017 May; 75(5):282-287. PubMed ID: 28591387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
    Mubaslat O; Lambert T
    Psychopharmacology (Berl); 2020 Oct; 237(10):2905-2915. PubMed ID: 32876732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study.
    Hyson HC; Johnson AM; Jog MS
    Mov Disord; 2002 Nov; 17(6):1318-20. PubMed ID: 12465075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atropine-induced toxicity after off-label sublingual administration of eyedrop for sialorrhoea treatment in neurological disabled patients.
    Michelon H; Larabi IA; Lemoine J; Alvarez JC; Genevée A; Lillo-Lelouet A; Azouvi P; Lefèvre-Dognin C; Paquereau J
    Br J Clin Pharmacol; 2021 Aug; 87(8):3364-3369. PubMed ID: 33521988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atropine drops for drooling: a randomized controlled trial.
    De Simone GG; Eisenchlas JH; Junin M; Pereyra F; Brizuela R
    Palliat Med; 2006 Oct; 20(7):665-71. PubMed ID: 17060265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual atropine drops for the treatment of pediatric sialorrhea.
    Rapoport A
    J Pain Symptom Manage; 2010 Nov; 40(5):783-8. PubMed ID: 20541902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of atropine in managing sialorrhea: A systematic review and meta-analysis.
    Yellepeddi VK; Race JA; McFarland MM; Constance JE; Fanaeian E; Murphy NA
    Int J Clin Pharmacol Ther; 2024 Jun; 62(6):267-277. PubMed ID: 38577753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual Atropine Administration for Clozapine-Induced Sialorrhea in Bipolar Disorder: A Case Report Highlighting its Efficacy, Safety Concerns and Challenges.
    Afroz O; Garg S; Kumar A; Kathiresan P; Mishra D; Deep R
    Psychopharmacol Bull; 2024 Aug; 54(4):124-130. PubMed ID: 39263201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of submandibular duct relocation on drooling and the well-being of children with neurodevelopmental disabilities.
    Kok SE; van der Burg JJ; van Hulst K; Erasmus CE; van den Hoogen FJ
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():173-8. PubMed ID: 27497408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of submandibular duct relocation in 91 children with excessive drooling: A prospective cohort study.
    Kok SE; Erasmus CE; Scheffer ART; van Hulst K; Rovers MM; van den Hoogen FJA
    Clin Otolaryngol; 2018 Dec; 43(6):1471-1477. PubMed ID: 29989346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
    Savarese R; Diamond M; Elovic E; Millis SR
    Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities.
    Van Hulst K; Van Der Burg JJ; Jongerius PH; Geurts AC; Erasmus CE
    Dev Med Child Neurol; 2020 Mar; 62(3):354-362. PubMed ID: 31729034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A as a treatment for excessive drooling in children.
    Bothwell JE; Clarke K; Dooley JM; Gordon KE; Anderson R; Wood EP; Camfield CS; Camfield PR
    Pediatr Neurol; 2002 Jul; 27(1):18-22. PubMed ID: 12160968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycopyrrolate for chronic drooling in children.
    Eiland LS
    Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual Atropine Sulfate Use for Sialorrhea in Pediatric Patients.
    Azapağası E; Kendirli T; Perk O; Kutluk G; Öz Tunçer G; Teber S; Çobanoğlu N
    J Pediatr Intensive Care; 2020 Sep; 9(3):196-200. PubMed ID: 32685247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of botulinum neurotoxin A in uncontrolled salivation in children with cerebral palsy: a pilot study.
    Tiigimäe-Saar J; Leibur E; Kolk A; Talvik I; Tamme T
    Int J Oral Maxillofac Surg; 2012 Dec; 41(12):1540-5. PubMed ID: 23068112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycopyrrolate for drooling in children with medical complexity under three years of age.
    Lovardi E; De Ioris MA; Lettori D; Geremia C; Staccioli S; Bella GD; Scrocca R; Scarselli A; Aversa M; De Peppo F; Campana A; Castelli E
    Ital J Pediatr; 2022 Jan; 48(1):2. PubMed ID: 34998418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
    Parr JR; Todhunter E; Pennington L; Stocken D; Cadwgan J; O'Hare AE; Tuffrey C; Williams J; Cole M; Colver AF
    Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
    Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
    Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.